These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36912655)

  • 1. Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine.
    Zhao X; Zhong X; Yang S; Deng K; Liu L; Song X; Zou Y; Li L; Zhou X; Jia R; Lin J; Tang H; Ye G; Yang J; Zhao S; Lang Y; Wan H; Yin Z; Kuipers OP
    Antimicrob Agents Chemother; 2023 May; 67(5):e0001023. PubMed ID: 36912655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BrevicidineB, a New Member of the Brevicidine Family, Displays an Extended Target Specificity.
    Zhao X; Kuipers OP
    Front Microbiol; 2021; 12():693117. PubMed ID: 34177875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel antimicrobial peptide with broad-spectrum and exceptional stability derived from the natural peptide Brevicidine.
    Yang P; Mao W; Zhang J; Yang Y; Zhang F; Ouyang X; Li B; Wu X; Ba Z; Ran K; Tian Y; Liu H; Zhang Y; Gou S; Zhong C; Ni J
    Eur J Med Chem; 2024 Apr; 269():116337. PubMed ID: 38537511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brevicidine acts as an effective sensitizer of outer membrane-impermeable conventional antibiotics for
    Zhong X; Deng K; Yang X; Song X; Zou Y; Zhou X; Tang H; Li L; Fu Y; Yin Z; Wan H; Zhao X
    Front Microbiol; 2023; 14():1304198. PubMed ID: 38173680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Total Chemical Synthesis and Biological Evaluation of the Cationic Antimicrobial Peptides, Laterocidine and Brevicidine.
    Hermant Y; Palpal-Latoc D; Kovalenko N; Cameron AJ; Brimble MA; Harris PWR
    J Nat Prod; 2021 Aug; 84(8):2165-2174. PubMed ID: 34338512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Structure-Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine B.
    Palpal-Latoc D; Horsfall AJ; Cameron AJ; Campbell G; Ferguson SA; Cook GM; Sander V; Davidson AJ; Harris PWR; Brimble MA
    J Nat Prod; 2024 Apr; 87(4):764-773. PubMed ID: 38423998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strain Brevibacillus laterosporus TSA31-5 produces both brevicidine and brevibacillin, exhibiting distinct antibacterial modes of action against Gram-negative and Gram-positive bacteria.
    Kim J; Kim J; Yun H; Ganbaatar B; Tahmasebi A; Seo SI; Kim PI; Lee CW
    PLoS One; 2024; 19(4):e0294474. PubMed ID: 38558002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
    Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification.
    Zhao X; Li Z; Kuipers OP
    Cell Chem Biol; 2020 Oct; 27(10):1262-1271.e4. PubMed ID: 32707039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and
    Al Ayed K; Ballantine RD; Hoekstra M; Bann SJ; Wesseling CMJ; Bakker AT; Zhong Z; Li YX; Brüchle NC; van der Stelt M; Cochrane SA; Martin NI
    Chem Sci; 2022 Mar; 13(12):3563-3570. PubMed ID: 35432860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining.
    Li YX; Zhong Z; Zhang WP; Qian PY
    Nat Commun; 2018 Aug; 9(1):3273. PubMed ID: 30115920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity.
    Ballantine RD; Al Ayed K; Bann SJ; Hoekstra M; Martin NI; Cochrane SA
    J Med Chem; 2023 Apr; 66(8):6002-6009. PubMed ID: 37071814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.
    Cochrane SA; Findlay B; Bakhtiary A; Acedo JZ; Rodriguez-Lopez EM; Mercier P; Vederas JC
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11561-11566. PubMed ID: 27688760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
    Huang E; Yang X; Zhang L; Moon SH; Yousef AE
    FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
    Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
    J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant
    Jangra M; Kaur M; Tambat R; Rana R; Maurya SK; Khatri N; Ghafur A; Nandanwar H
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of gram-negative bacteria by targeting the membrane potential.
    Goldberg K; Sarig H; Zaknoon F; Epand RF; Epand RM; Mor A
    FASEB J; 2013 Sep; 27(9):3818-26. PubMed ID: 23733749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Membrane Curvature Modulated Lipopeptide to Broadly Combat Multidrug-Resistant Bacterial Pneumonia with Low Resistance Risk.
    Zou P; Liu J; Li X; Yaseen M; Yao J; Liu L; Luo L; Wang H; Shi X; Li Z; Sun T; Gao Y; Gao C; Li LL
    ACS Nano; 2022 Dec; 16(12):20545-20558. PubMed ID: 36375012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.